









Markets
/
Stocks
/
nasdaq-zyxi
/

Zynex Inc

ZYXI

1.130USD

-0.010-0.88%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

34.66MMarket Cap

25.22P/E TTM



Zynex Inc

1.130

-0.010-0.88%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Zynex Inc

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Zynex Inc's Score

Industry at a Glance

Industry Ranking

128 / 210

Overall Ranking

294 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

4.567

Target Price

+300.59%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Zynex Inc Highlights

StrengthsRisks

Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 21.61% year-on-year.

Undervalued

The company’s latest PE is -1.22, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 5.07M shares, decreasing 51.33% quarter-over-quarter.

Held by Chuck Royce

Star Investor Chuck Royce holds 17.69K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.99.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 6.76, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 22.29M, representing a year-over-year decrease of 55.32%, while its net profit experienced a year-over-year decrease of 1746.10%.

Score

Industry at a Glance

Previous score

6.76

Change



Financials

5.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.81

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.55

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.80

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.18

Key Metrics

Free cash flow

No Data

Zynex Inc's Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 8.24, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -1.22, which is -7427.48% below the recent high of 89.18 and -810.52% above the recent low of -11.08.

Score

Industry at a Glance

Previous score

8.24

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 128/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

The company’s current earnings forecast score is 7.33, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Zynex Inc is 3.70, with a high of 8.00 and a low of 2.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

4.567

Target Price

+300.59%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Zynex Inc

ZYXI

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 5.13, which is lower than the Healthcare Equipment & Supplies industry's average of 6.82. Sideways: Currently, the stock price is trading between the resistance level at 1.40 and the support level at 0.98, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.10

Change

0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.038

Sell

RSI(14)

26.985

Sell

STOCH(KDJ)(9,3,3)

9.408

Oversold

ATR(14)

0.081

High Vlolatility

CCI(14)

-132.211

Sell

Williams %R

89.474

Oversold

TRIX(12,20)

-0.728

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.166

Sell

MA10

1.259

Sell

MA20

1.318

Sell

MA50

1.432

Sell

MA100

1.774

Sell

MA200

2.947

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-05

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 16.72%, representing a quarter-over-quarter decrease of 76.26%. The largest institutional shareholder is The Vanguard, holding a total of 947.72K shares, representing 3.13% of shares outstanding, with 6.03% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Sandgaard (Thomas)

14.31M

-10.72%

The Vanguard Group, Inc.

Star Investors

947.72K

-9.64%

Two Sigma Investments, LP

518.62K

+90.65%

BlackRock Institutional Trust Company, N.A.

505.68K

-53.56%

Arrowstreet Capital, Limited Partnership

247.70K

-4.06%

Susquehanna International Group, LLP

241.92K

+532.53%

Millennium Management LLC

215.23K

+1260.76%

Geode Capital Management, L.L.C.

189.41K

-51.06%

Renaissance Technologies LLC

Star Investors

172.26K

+14.64%

D. E. Shaw & Co., L.P.

152.37K

+4.22%

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 1.59, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.86. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.